Zimmer Biomet Holdings (ZBH) Income towards Parent Company (2009 - 2026)
Zimmer Biomet Holdings (ZBH) recorded quarterly Income towards Parent Company of $238.3 million in Q1 2026, down 10.21% quarter-over-quarter from $265.4 million in Q4 2025, and up 30.58% on a YoY basis from $182.5 million in Q1 2025.
Zimmer Biomet Holdings (ZBH) Income towards Parent Company (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Income towards Parent Company history runs 18 years deep, the most recent figure standing at $238.3 million for Q1 2026.
- In Q1 2026, Income towards Parent Company rose 30.58% year-over-year to $238.3 million; the TTM figure through Mar 2026 stood at $888.3 million (up 33.96% YoY), while the FY2025 annual figure was $832.6 million, changed N/A from the prior year.
- Income towards Parent Company was $238.3 million for Q1 2026 at Zimmer Biomet Holdings, down from $265.4 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $419.7 million in Q4 2023 to a low of -$58.8 million in Q1 2022.
- Historically, Income towards Parent Company has averaged $192.2 million across 5 years, with a median of $220.6 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Income towards Parent Company slumped 1351.06% in 2022, then surged 2368.38% in 2025.
- A 5-year view of Income towards Parent Company shows it stood at -$58.8 million in 2022, then surged by 813.78% to $419.7 million in 2023, then tumbled by 102.79% to -$11.7 million in 2024, then soared by 2368.38% to $265.4 million in 2025, then decreased by 10.21% to $238.3 million in 2026.
- The last three Income towards Parent Company figures came in at $238.3 million (Q1 2026), $265.4 million (Q4 2025), and $231.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 238.30 Mn |
| Dec 31, 2025 | 265.40 Mn |
| Sep 30, 2025 | 231.20 Mn |
| Jun 30, 2025 | 153.40 Mn |
| Mar 31, 2025 | 182.50 Mn |
| Dec 31, 2024 | -11.70 Mn |
| Sep 30, 2024 | 249.20 Mn |
| Jun 30, 2024 | 243.10 Mn |
| Mar 31, 2024 | 172.80 Mn |
| Dec 31, 2023 | 419.70 Mn |
| Sep 30, 2023 | 162.80 Mn |
| Jun 30, 2023 | 209.90 Mn |
| Mar 31, 2023 | 232.70 Mn |
| Mar 31, 2022 | -58.80 Mn |
| Dec 31, 2021 | -29.20 Mn |
| Sep 30, 2021 | -16.60 Mn |
| Jun 30, 2021 | -2.30 Mn |
| Mar 31, 2021 | 4.70 Mn |
| Dec 31, 2020 | 401.30 Mn |
| Sep 30, 2020 | 246.10 Mn |